Toward the future management of patients with CML and Ph + ALL: real-world safety insights from dasatinib pharmacovigilance.

Front Med (Lausanne) · 2025 · PMC12815812 · PMID 41567666

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Primary effusion lymphoma, another highly significant sign, is a rare but serious potential complication.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.